Hospitals urge Congress to maintain support for 340B program

Listen

The American Hospital Association has called on Congress to preserve the 340B Drug Pricing Program in a statement submitted to the House Energy and Commerce Health Subcommittee.

The statement, which was provided for a hearing examining the program, highlighted how the 340B program helps hospitals improve access to comprehensive healthcare services for more patients.

"Given the increasingly high cost of pharmaceuticals, the 340B program remains critical," and scaling it back would have "devastating consequences for patients and communities," the AHA said in the statement.

More articles on healthcare finance:

Hospitals' uncompensated care costs fell by $7.4B last year
Subsidies are central part of PPACA's success, GAO says
Details on Banner Health's $86M facility in Colorado released

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Whitepapers

Featured Webinars